Gene Therapy for Arthritis, Musculoskeletal, and Skin Diseases Group leaders and participants -Dr. Glen Nuckolls -Dr. Paul Robbins Program Director Professor,

Slides:



Advertisements
Similar presentations
The way forward: Development of joint S&T Human Capital Dr. Agrita Kiopa, Ministry of Education and Science
Advertisements

Miami CTSI--Culturalized Health Sciences for a Healthier South Florida! Clinical & Translational Science Institutes The U.S.A. launches an initiative to.
Replacement of Defective Genes A story of familial hypercholesterolemia By, Russell Brown, Amber Ellis, and Stacey Leonard.
Zeroing in on Non-Small Cell Lung Cancer: Integrating Targeted Therapies into Practice.
Retreat Topics iPSC Opportunities in NIAMS Diseases Science Management Forum: Leveraging and Strategic Funding Collaborations Atopic Dermatitis Advancing.
The Division of Monoclonal Antibodies Kathleen A. Clouse, Ph.D., Director CTGTAC - July 26, 2007.
Therapy of enzyme defects: general considerations ● How many organs are affected by the enzyme defect: One organ, a few, or all organs? ● How severe is.
METHODS Each intern conducted subject matter research as independent study format (from home or library) within the Intern Team Surveyed public literature.
1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.
Center for Biologics Evaluation and Research Applying Regulatory Science to Advance Development of Innovative, Safe and Effective Biologic Products Carolyn.
Center for Biologics Evaluation and Research FDA Overview Site Visit Carolyn A. Wilson, Ph.D. Associate Director for Research.
Gene therapy progress and prospects cancer. Gene Therapy Primary challenge for gene therapy – Successfully delivery an efficacious dose of a therapeutic.
The NIH Roadmap for Medical Research
Welcome to the Fall 2010 TBPT Meeting Dr. Paul Klotman President and CEO Baylor College of Medicine November 3, 2010.
Osteoarthritis (OA): Updates on development, treatment and possible prevention Kevin Deane, MD/PhD Associate Professor of Medicine Division of Rheumatology.
Long-Term Follow-Up of Subjects in Gene Transfer Clinical Protocols Vector Classes with Potential for Long-Term Risks Carolyn A. Wilson, Ph.D. Division.
8/27/2015 | 1 Dutch Universities: Research with Focus on Top Sectors. Cooperation with Russia in Field of Life-Science & Health Sibrandes Poppema 400 years.
NIAMS Extramural Scientific Planning Retreat 2013 April 4, 2013 Session 2: The Circadian Cycle in NIAMS-Relevant Tissues.
Institute on Systems Science and Health- Federal Funding Panel Grace C.Y. Peng, Ph.D. May 25, 2011.
Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.
NCRR American Society of Plant Biologists NIH Science Education Partnership Award (SEPA)
Optimization of Stem cell Therapy for degenerative Epithelial & Muscle Diseases March 2009 – February
Influenza Vaccine Development
Stem Cell KSU. Stem Cell – Definition A cell that has the ability to continuously divide and differentiate (develop) into various other kind(s) of cells/tissues.
System Director, Oncology Service Line
Gene Therapy and Genetic Counseling. Treating Genetic Diseases Protein-based therapiesProtein-based therapies Disease Therapeutic Agent Cystic Fibrosis.
2010 NIAMS Scientific Retreat Comparative Effectiveness Research Institute of Medicine Priorities Functional Limitations & Disabilities Endocrinology &
Detecting Genetic Diseases Karyotyping Amniocentisis Chorionic Villus Sampling (CVS) Adult Karyotyping FISH RFLPs SNPs Microarray Analysis.
SYNBIOLOGY - An Analysis of Synthetic Biology Research in Europe and North America 4,5/4,5 CM SYNBIOLOGY: An Analysis of Synthetic Biology Research in.
PROTOCOL 588: OVERALL ASSESSMENT Concept is sound, well supported Vector is safe Transgene product is reasonably safe Overall, a phase I study seems acceptable.
Special NIH Funding Opportunities
Medical Education Paul J. McDermott, Ph.D. Associate Dean for Faculty Affairs and Development Office:
Current Areas of Space-Related Health Research Basic Bone Biology –the role of the osteocyte in sensing the loading environment – potential new target.
Establishing Defra’s evidence needs Dr Steven Hill Chief Scientific Adviser’s Secretariat, Science Directorate.
Goals: –Review ongoing and emerging areas of science –Identify needs, gaps, and opportunities that would not be pursued otherwise –Review funding mechanisms.
Discovery: Stem Cell Biology Proposed Actions Continue infrastructure award program Characterize cell lines Stimulate more research on basic biology Train.
Consortium for Interdisciplinary Studies on Science for Aging.
OMICS International welcomes submissions that are original and technically so as to serve both the developing world and developed countries in the best.
1 Jin-Soo Kim Dept. of Chemistry, Seoul National Univ. Center for Genome Engineering, Institute for Basic Science Genome Editing: Challenges and Opportunities.
Group leader and participants Chronic Pain -Dr. Daniel Clauw Associate Dean for Clinical and Translational Research and Director, Chronic Pain and Fatigue.
Ancillary Studies to Large Clinical Projects Group leaders and participants -Dr. Joan McGowan Director, Division of Musculoskeletal Diseases, NIAMS -Dr.
Cancers of the Digestive System November 19, 2007 NCDD Meeting Chair: John M. Carethers, MD Vice Chair: Robert Sandler, MD, MPH.
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
CBER Research: OBRR Office Site Visit Kathryn M. Carbone, MD Associate Director of Research CBER/FDA.
Research in the Office of Cellular, Tissue and Gene Therapies: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation.
Center for Biologics Evaluation and Research, FDA Site Visit Introduction Kathryn M. Carbone, M.D. Associate Director for Research.
Gene Therapy (I) “Introduction to Gene Therapy”
NIAMS Extramural Scientific Planning Retreat 2013 April 4, 2013 Session 1: Strategies for Successful Rare Disease Clinical Trials.
OSTEOARTHRITIS OF THE KNEE DR. IRA GELB, POTOMAC VALLEY ORTHOPEDICS Kiran Pant, Intern/Mentor Program Mount Hebron High School.
NIAMS Training Program Group leader and participants: – Madeline Turkeltaub, CRNP, Ph.D. Director, Division of Extramural Research Activities, NIAMS –
M ax D elbrück L ecture Date:June 17th, 2008 Speaker: Kenneth R. Chien MGH Cardiovascular Research Center Boston, USA Title:Toward human models of human.
Stem Cells: Scientific Potential and Alternatives
Stem Cells in Wound Healing: The Future of Regenerative Medicine
Dr. Peter John M.Phil, PhD Atta-ur-Rahman School of Applied Biosciences (ASAB) National University of Sciences & Technology (NUST)
James M. Fadool Biological Science
Biomedical Therapies Foundation Standard 1: Academic Foundation
Action: BM0806 Recent Advances in Histamine Receptor H4R Research
OMICS Journals are welcoming Submissions
OATech+ Network: Using Technology to work towards improving Patient Outcomes Leanne Sawle.
Trinity College Dublin 12 April 2018 Hugh McMahon
Figure 1 Induction of immune tolerance
Genome-editing Technologies for Gene and Cell Therapy
CBTTC Fiscal Year 18 Strategic Objectives
Trial Funding and Engagement: The NIH Sponsored CTSA Program
Retreat Topics iPSC Opportunities in NIAMS Diseases
Genome-editing Technologies for Gene and Cell Therapy
Multiple Sclerosis is a neurological, immune-mediated disorder
Stem cells What is stem cells therapy ? A stem cell is a type of cell not specialized to perform a specific role. Stem cell therapy uses stem cells to.
Stem cells What is stem cells therapy ? A stem cell is a type of cell not specialized to perform a specific role. Stem cell therapy uses stem cells to.
Exploring the Use of Adeno-Associated Virus for Gene Therapy
Presentation transcript:

Gene Therapy for Arthritis, Musculoskeletal, and Skin Diseases Group leaders and participants -Dr. Glen Nuckolls -Dr. Paul Robbins Program Director Professor, Microbiology and Molecular Genetics, Division of Musculoskeletal Diseases, NIAMS and Biochemistry University of Pittsburgh -Dr. Carl C. Baker Program Director Division of Skin and Rheumatic Diseases, NIAMS -Dr. Dennis Roop Charles C. Gates Chair of Regenerative Medicine and Stem Cell Biology -Ms. Shahnaz Khan University of Colorado Denver Clinical Coordinator Division of Extramural Research Activities, NIAMS -Ms. Anna Nicholson Clinical Coordinator Division of Extramural Research Activities, NIAMS -Dr. Louise Rosenbaum Science Policy Analyst Office of Science Policy and Planning, NIAMS Overarching question -What high priority, basic research questions should be addressed to advance the field of gene therapy? 2008 NIAMS Scientific Retreat

Uses of Gene Therapy Advantages of gene therapy (GT) -Potential replacement or correction of single gene defects -Up- or down-regulation of pathways involved in pathology or natural repair mechanisms -Synthesis, processing, and delivery of GT products at the disease site Application of GT to Arthritis, Musculoskeletal, and Skin Diseases -Wound-healing: delivery of platelet-derived growth factor b gene to lesions -Rheumatoid arthritis: injection of ex vivo-manipulated synovial cells into joints -Osteoarthritis: targeting interleukin 1 receptor antagonist gene to affected knee joints -Limb-girdle muscular dystrophy: intramuscular delivery of alpha-sarcoglycan gene 2008 NIAMS Scientific Retreat

Points of consideration Vector optimization, selection, and delivery -In vivo delivery, ex vivo manipulation options -Stem cells: only curative approach Immune response -Primary obstacle for successful GT -Approaches: transient immune suppression, long-term tolerance strategies Infrastructure and resource needs -Central services for pre-clinical testing and vector production -Activities (meetings, funding opportunities) to facilitate formation of multidisciplinary collaborations Regulatory and review issues -Increased federal requirements -Importance of multidisciplinary peer review for GT grant applications 2008 NIAMS Scientific Retreat